|
|
||||||||
Articles |
1
Department of Pediatrics, Indiana University, Indianapolis, IN 46202.
2
Department of Pediatrics, Stanford University Medical
Center, Stanford, CA 94304.
3
Neonatal Network, National Institute of Child Health and
Human Development, Bethesda, MD 20892.
4
Department of Biomedical Engineering, Children's
Hospital National Medical Center, Washington, DC 20010.
5
Analytical Chemistry Division, National Institute of
Standards and Technology, Gaithersburg, MD 20899.
6
Identification of commercial equipment in this article is to provide as complete a description of the experimental procedures followed as possible. Such identification does not constitute a recommendation or endorsement by NIST of the vendor or equipment.
a Address correspondence to this author at: Division of Neonatal-Perinatal Medicine, Indiana University School of Medicine, 702 Barnhill Drive, Room RR-208, Indianapolis, IN 46202. Fax 317-274-2065; e-mail gsokol{at}iupui.edu
Background: Nitrogen dioxide (NO2) is a toxic by-product of inhalation therapy with nitric oxide (NO). The rate of NO2 formation during NO therapy is controversial.
Methods: The formation of NO2 was studied under dynamic flows emulating a base case NO ventilator mixture containing 80 ppm NO in a 90% oxygen matrix. The difficulty in measuring NO2 concentrations below 2 ppm accurately was overcome by the use of tunable diode laser absorption spectroscopy.
Results: Using a second-order model, the rate constant, k, for NO2 formation was determined to be (1.19 ± 0.11) x 10-11 ppm-2s-1, which is in basic agreement with evaluated data from atmospheric literature.
Conclusions: Inhaled NO can be delivered safely in a well-designed, continuous flow neonatal ventilatory circuit, and NO2 formation can be calculated reliably using the rate constant and circuit dwell time. © 1999 American Association for Clinical Chemistry
The following articles in journals at HighWire Press have cited this article:
![]() |
K. P. Van Meurs Inhaled Nitric Oxide Therapy in the Preterm Infant Who Has Respiratory Distress Syndrome NeoReviews, June 1, 2005; 6(6): e268 - e277. [Full Text] [PDF] |
||||
![]() |
F. Ichinose, J. D. Roberts Jr, and W. M. Zapol Inhaled Nitric Oxide: A Selective Pulmonary Vasodilator: Current Uses and Therapeutic Potential Circulation, June 29, 2004; 109(25): 3106 - 3111. [Full Text] [PDF] |
||||
![]() |
T. KOBAYASHI, E. C. GABAZZA, S. SHIMIZU, H. YASUI, H. YUDA, O. HATAJI, K. MARUYAMA, T. YAMAUCHI, K. SUZUKI, Y. ADACHI, et al. Long-term Inhalation of High-dose Nitric Oxide Increases Intraalveolar Activation of Coagulation System in Mice Am. J. Respir. Crit. Care Med., June 1, 2001; 163(7): 1676 - 1682. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Weinberger, D. L. Laskin, D. E. Heck, and J. D. Laskin The Toxicology of Inhaled Nitric Oxide Toxicol. Sci., January 1, 2001; 59(1): 5 - 16. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |